SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): November 4, 2004
OPHTHALMIC IMAGING SYSTEMS
--------------------------
(Exact Name of Registrant as Specified in its Charter)
CALIFORNIA 1-11140 94-3035367
- --------------------------------------------------------------------------------
(State or Other Jurisdiction of (Commission File Number) (I.R.S. Employer
Incorporation) Identification No.)
221 Lathrop Way, Suite I
Sacramento, California 95815
- --------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(Registrant's telephone number, including area code): (916) 646-2020
Not Applicable
- --------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
|_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
The following information, including Exhibit 99.1 and the information
therefrom incorporated herein by reference, is being furnished, and shall not be
deemed "filed," for purposes of Section 18 of the Securities and Exchange Act of
1934, as amended, or otherwise subject to the liability of that section, nor
shall it be deemed incorporated by reference in any filing under the Securities
Act of 1933, as amended, except as shall be expressly set forth by specific
reference in such a filing.
Item 2.02. Results of Operations and Financial Condition.
---------------------------------------------
On November 4, 2004 the Company issued a press release announcing its
results of operations for the Company's third quarter and nine months ended
September 30, 2004. A copy of the press release is furnished as Exhibit 99.1 to
this Report and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
---------------------------------
(a) Financial Statements of Business Acquired: None
(b) Pro Forma Financial Information: None
(c) Exhibits:
99.1 The Company's press release dated November 4, 2004.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Date: November 4, 2004 OPHTHALMIC IMAGING SYSTEMS
By: /s/ Ariel Shenhar
--------------------------------------
Name: Ariel Shenhar
Title: Chief Financial Officer, Vice
President, and Secretary
EXHIBIT INDEX
-------------
Exhibit
Number Description
- ------ -----------
99.1 Press Release of the registrant dated November 4, 2004.